Group

As per Data Bridge Market Research analysis, the peripheral arterial disease (PAD) market was valued at USD 873.01 million in 2025 and is projected to reach USD 1,739.52 million by 2033, growing at a CAGR of 9.00% from 2026 to 2033.

Growth is primarily driven by the rising prevalence of PAD due to aging populations, increasing risk factors such as diabetes and hypertension, and continued advancements in minimally invasive treatment options.

The rising incidence of cardiovascular diseases, growing awareness about PAD, advancements in diagnostic technologies, and the development of innovative treatment options such as drug-eluting stents and atherectomy devices are further strengthening market growth.

The growing global focus on minimally invasive techniques such as endovascular surgery, which ensure faster recovery times and better patient outcomes, continues to reposition PAD treatment as a critical priority within cardiovascular care.